Want to know more?
Why not download the full presentation about NIAID Influenza vaccine development: Informed by rapid responses to viral outbreaks
- How has NIAID responded to support pandemic and seasonal influenza preparedness?
- What are NIAIDs preclinical resources and clinical trial infrastructure capabilities for influenza response?
- What future areas have been identified for NIAID preclinical and clinical support?
Dr David Spiro, Chief of the Influenza, SARS, & Related Viral Respiratory Diseases Section, Respiratory Diseases Branch, Division of Microbiology and Infectious Diseases,
NIAID/NIH, joined us at the World Vaccine Congress Washington to update us on the important work of the NIAID, in partnership with BARDA, in the fight against flu.
Tell us what you think in the space provided below!